On March 9, 2020, the Federal Trade Commission and the Food and Drug Administration will co-sponsor a public workshop on promoting competition in biologics markets. The workshop will be held at the FDA’s White Oak Campus in Silver Spring, Maryland and will also be webcast.
Workshop panelists will discuss the agencies’ efforts to support competition between biosimilars and reference biologics, discouraging false or misleading statements about biosimilars’ safety and efficacy, and deterring anti-competitive behaviors in the biologic marketplace. Last month, the FTC and the FDA signed a joint statement promoting competition in markets for biologics.
For more information about viewing the webcast, and for background information on the event, see the FDA’s meeting announcement. All available tickets for onsite seating are reserved, but registration for the webcast is still available. The webcast will also be archived for later viewing.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Sign me up for the newsletter!
Notify me of follow-up comments by email.
Notify me of new posts by email.
Anil Rawal appointed as the Chief Executive Officer of IntelliSmart
McDonald’s India introduces a unique ‘Work from Home’ policy for its Restaurant Management Team and Frontline Crew
Sony Pictures Networks (SPN) pledges INR 100 million to Film and Television industry daily wage earners affected by unemployment during the COVID-19 pandemic
Here’s how CD Leganes continue training with LaLiga suspended and Spain in lockdown
Myntra partners with Wildcraft to offer personal protective face masks on its platform
2014 The Global Indian New Network (TGINN)